European Consumers Use of Internet for Pharmaceutical Information

Manhattan ResearchIn today's world of fragmented media and channel mix, it is increasingly difficult to isolate the information sources used by consumers to research health information and inform healthcare decision making. This is especially the case across Europe, where consumers are accessing an expanding range of resources which vary greatly by country and by region.

Enter Cybercitizen® Health Europe, a new research study and advisory service offered by Manhattan Research. This study provides pharmaceutical and healthcare companies with key data about the evolving nature of consumer channel mix, media and technology usage, and healthcare information with the goal of helping companies understand how consumers across Europe access health information, and how they use that information to make critical healthcare decisions for themselves and their families.

In addition to defining broad online health technology trends, Cybercitizen® Health Europe will investigate topics such as Internet usage, search engine usage, local European versus global websites, product websites, health portals, health information seeking methods, email communication, patient-physician interactions, unbranded patient education, health e-commerce and more. Furthermore, the study will reveal leading health and pharma websites based on the number of visiting European consumers, while detailing consumer satisfaction with site content and features.

Webinar Presentation
A free, private webinar is offered to qualified business accounts to review additional information about Cybercitizen® Health Europe as well as charter sponsorship details. Please visit www.manhattanresearch.com/ccheu.aspx to register for the webinar or to request additional information.

The Cybercitizen® Health Europe syndicated multi-client study and advisory service will be fielded as an online panel study among 3,300 European consumers in total from the United Kingdom, Germany, Spain, Italy, France, Belgium, Sweden, the Netherlands, Poland, and Portugal. The study will explore these topics and many more:

  • Overall media consumption
  • Frequency and types of Internet access
  • Technology adoption like MP3/iPod, PDA, SMS messaging, Smartphones
  • Advanced activities online like online video, blogs, podcasting, wikis
  • Use and relative influence of physicians, nurses, pharmacists, friends and family
  • Search engine reliance and behaviour
  • Use and interest in health email newsletters, support groups, chat rooms, and disease management tools
  • Interest in Web 2.0 technologies for health and pharmaceutical information

About Manhattan Research Products and Service
In addition to Cybercitizen® Health Europe, Manhattan Research conducts five annual research studies among consumers and physicians in the United States and in Europe. These studies include Cybercitizen® Health US, Taking the Pulse® Europe, Taking the Pulse® US, ePharma Physician®, and ePharma Consumer®. Each study serves a unique purpose and focuses on specific aspects of information technology adoption. Broad consumer and physician research is complemented by targeted analysis among more than 50 consumer therapeutic segments and 25 physician specialist segments. For further information, please visit www.manhattanresearch.com

Most Popular Now

Accelerating NHS Digital Maturity: Paper…

Digitised clinical noting at South Tees Hospitals NHS Foundation Trust is creating efficiencies for busy doctors and nurses. The trust’s CCIO Dr Andrew Adair, deputy CCIO Dr John Greenaway, and...

AI Tool Helps Predict Who will Benefit f…

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who...

New Study Shows Promise for Gamified mHe…

A new study published in Multiple Sclerosis and Related Disorders highlights the potential of More Stamina, a gamified mobile health (mHealth) app designed to help people with Multiple Sclerosis (MS)...

AI in Healthcare: How do We Get from Hyp…

The Highland Marketing advisory board met to consider the government's enthusiasm for AI. To date, healthcare has mostly experimented with decision support tools, and their impact on the NHS and...

Research Shows AI Technology Improves Pa…

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement disorders...

New AI Tool Accelerates Disease Treatmen…

University of Virginia School of Medicine scientists have created a computational tool to accelerate the development of new disease treatments. The tool goes beyond current artificial intelligence (AI) approaches by...

DMEA sparks: The Future of Digital Healt…

8 - 10 April 2025, Berlin, Germany. Digitalization is considered one of the key strategies for addressing the shortage of skilled workers - but the digital health sector also needs qualified...

First Therapy Chatbot Trial Shows AI can…

Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the software resulted in significant improvements in participants' symptoms, according to results...

Who's to Blame When AI Makes a Medi…

Assistive artificial intelligence technologies hold significant promise for transforming health care by aiding physicians in diagnosing, managing, and treating patients. However, the current trend of assistive AI implementation could actually...

DeepSeek: The "Watson" to Doct…

DeepSeek is an artificial intelligence (AI) platform built on deep learning and natural language processing (NLP) technologies. Its core products include the DeepSeek-R1 and DeepSeek-V3 models. Leveraging an efficient Mixture...

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...